| | | | | Patients on drug pricing. Pfizer after Covid. A pharma legend's social justice quest. Vertex's pivot. We'll tackle all these topics at the STAT Summit this Nov. 15-16. Get your ticket here to join us. | | | | By Sarah Owermohle Justin Sullivan/Getty Images Kari Lake and fellow GOP candidates are questioning the legitimacy of abortion, vaccines, the coronavirus response and gender-affirming care. Read More | | By Megan Molteni Adobe These brain implants are still far from producing natural speech in real-time from continuous thoughts. But that reality is inching closer. Read More | | By Mario Aguilar Stephan Melzer/Alamy Talkspace, the virtual mental health company, appointed a new CEO, and key numbers continue to point in the right direction. Read More | | Sponsored Insight by UnitedHealthcare What older adults really want from their dental benefits in 2023 In a new survey, 800+ older adults reveal their most common oral health concerns, what's important to them when it comes to dental coverage, and why their plans are often complicated, confusing, limited—and a significant source of frustration. Fortunately, new dental benefit solutions are prioritizing value, clarity, and cost savings, and giving older adults what they need and deserve. Download the free report to learn more. | | By Ed Silverman Adobe "The court may have wanted to wade into this complex area one toe at a time," said Robin Feldman of the University of California Hastings. Read More | | By Allison Empey STEFANI REYNOLDS/AFP via Getty Images The Indian Child Welfare Act protects Native American children. Weakening or dismantling it would be a grave error. Read More | | By Associated Press Justin Sullivan/Getty Images A federal judge rejected a bid for a new trial for former Theranos CEO Elizabeth Holmes, who now faces up to 20 years in prison. Read More | | By Susan Arnold Win McNamee/Getty Images Access to real-time data can be invaluable for gauging the health effects of natural or manmade disaster on communities and relief workers. Read More | |
No comments